References
- Grassly NC, Jafari H, Bahl S et al. Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination. J. Infect. Dis.201, 1535–1543 (2010).
- Bodian D. Emerging concept of poliomyelitis infection. Science122, 105–108 (1955).
- Ghendon YZ, Sanakoyeva II. Comparison of the resistance of the intestinal tract to poliomyelitis virus (Sabin’s strains) in person after naturally and experimentally acquired immunity. Acta Virol.5, 265–273 (1961).
- Henry JL, Jaikaran ES, Davies JR et al. A study of polio vaccination in infancy: excretion following challenge with live virus by children given killed or living polio vaccine. J. Hyg.6, 105–120 (1966).
- Fox JP, Gelfand HM, LeBlanc DR, Rowan DF. The influence of natural and artificially induced immunity on alimentary infections with polioviruses. Am. J. Public Health9, 1181–1192 (1958).
- Onorato IM, Modlin JF, McBean AM, Thoms ML, Losonsky GA, Bernier RH. Mucosal immunity induced by enhanced potency IPV and OPV. J. Infect. Dis.163, 1–6 (1991).
- Marine WM, Chin TD, Gravelle CR. Limitation of fecal and pharyngeal poliovirus excretion in Salk-vaccinated children: a family study during a type 1 poliomyelitis epidemic. Am. J. Hyg.76, 173–195 (1962).
- The Cuba IPV Study Collaborative Group. Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba. N. Engl. J. Med.356, 1536–1544 (2007).
- Faden H, Modlin JF, Thoms ML, McBean AM, Ferdon MB, Ogra PL. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J. Infect. Dis.162, 1291–1297 (1990).
- Böttiger M. Polio immunity to killed vaccine: an 18-year follow up. Vaccine8, 443–445 (1990).
- Vekemans J, Ota MO, Wang EC et al. T cell responses to vaccines in infants: defective IFN gamma production after oral polio vaccination. Clin. Exp. Immunol.127, 495–498 (2002).
- Klein NP, Gans HA, Sung P et al. Preterm infants’ T cell responses to inactivated poliovirus vaccine. J. Infect. Dis.201, 214–222 (2010).
- Honda K, Takeda K. Regulatory mechanisms of immune responses to intestinal bacteria. Mucosal Immunol.2, 187–195 (2009).
- World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine. Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. J. Infect. Dis.171, 1097–1106 (1995).
Website
- Meeting of experts: December 2010, Delhi, India www.polioeradication.org/Research/OPVefficacy/MucosalImmunityPoliovaccinemeeting.aspx